Biomea Fusion, Inc.

BMEA

$1.97

+3.34%

N/A+$0.06

Healthcare

Biotechnology

NASDAQ

Active Trading

Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients ...

C-Suite Executives

(0)

The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.

Key Team Members

No executives available for this level

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Gender	Year Born	Status
Michael J. Hitchcock	Interim Chief Executive Officer & Director	USD 867,935	—	1950	Active
Ramses Erdtmann	Co-Founder, President, Chief Operating Officer & Director	USD 636,485		1963	Active
Caroline Perez- Dupont	Senior Vice President of Legal	—	—	—	Active
Heow Tan	Chief Technology & Quality Officer	—		1959	Active
Stephan Morris	Chief Development Officer	—	—	—	Active
Ravi Upasani	Executive Vice President of Intellectual Property	—		—	Active
Thorsten Kirschberg	Executive Vice President of Research	—	—	1970	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total
2026-04-27	2025	Michael J.M. Hitchcock, Ph.D. Interim	Chief Chief Executive Officer and Principal Principal Executive Officer	Founder / CEO	$486.74K	$220.08K	$0	$1.85M	$0	$14.13K	$2.57M
2026-04-27	2025	Rainer (Ramses) Erdtmann	Chief Chief Operating Officer, President President, Principal Principal Financial Officer and Principal Principal Accounting Officer	C-Level	$489.60K	$146.88K	$0	$1.57M	$0	$0	$2.21M
2026-04-27	2025	Thomas Butler	Former Former Chief Chief Executive Officer and Former Former Chairman of the Board	Founder / CEO	$148.80K	$0	$0	$0	$0	$513.16K	$661.96K
2026-04-27	2025	Juan Pablo Frias, M.D.	Former Former Chief Chief Medical Officer	C-Level	$325.00K	$0	$0	$158.71K	$0	$65.33K	$549.04K
2026-04-27	2024	Thomas Butler	Former Former Chief Chief Executive Officer and Former Former Chairman of the Board	Founder / CEO	$633.60K	$0	$0	$4.47M	$0	$0	$5.11M
2026-04-27	2024	Rainer (Ramses) Erdtmann	Chief Chief Operating Officer, President President, Principal Principal Financial Officer and Principal Principal Accounting Officer	C-Level	$489.60K	$0	$0	$1.49M	$0	$0	$1.98M

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

Supply Chain of BMEA

RELATIONS

Upstream

Contract Manufacturing Organizations (Small Molecule CDMOs)UnconfirmedContract Research Organizations (CROs) — Clinical OperationsUnconfirmedPreclinical CROs & Laboratory Service ProvidersUnconfirmedActive Pharmaceutical Ingredient (API) Raw Material SuppliersSpecialty Chemical & Reagent VendorsUniversity of Leicester / Leicester Diabetes Centre

Downstream

University of Leicester / Leicester Diabetes CentreFuture Pharmacy Benefit Managers / WholesalersPatients / Healthcare Providers (Target End Market)

Proxies

Structure TherapeuticsNASDAQ:GPCR Viking TherapeuticsNASDAQ:VKTXKallyope, Inc.UnconfirmedCarmot Therapeutics (acquired by Roche)Unconfirmed

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer